These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8600892)

  • 21. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.
    Gilger BC; Malok E; Stewart T; Horohov D; Ashton P; Smith T; Jaffe GJ; Allen JB
    Vet Immunol Immunopathol; 2000 Oct; 76(3-4):239-55. PubMed ID: 11044557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes.
    Theng JT; Ti SE; Zhou L; Lam KW; Chee SP; Tan D
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4895-9. PubMed ID: 14578414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and Safety Evaluation of a Transscleral Sustained Unoprostone Release Device in Monkey Eyes.
    Nagai N; Yamada S; Kawasaki J; Koyanagi E; Saijo S; Kaji H; Nishizawa M; Nakazawa T; Abe T
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):644-652. PubMed ID: 29392308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.
    Jaffe GJ; Yang CH; Guo H; Denny JP; Lima C; Ashton P
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3569-75. PubMed ID: 11006254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
    He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.
    Yang CS; Khawly JA; Hainsworth DP; Chen SN; Ashton P; Guo H; Jaffe GJ
    Arch Ophthalmol; 1998 Jan; 116(1):69-77. PubMed ID: 9445210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant.
    Park J; Bungay PM; Lutz RJ; Augsburger JJ; Millard RW; Sinha Roy A; Banerjee RK
    J Control Release; 2005 Jul; 105(3):279-95. PubMed ID: 15896868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
    Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
    Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes.
    Fialho SL; Rêgo MB; Siqueira RC; Jorge R; Haddad A; Rodrigues AL; Maia-Filho A; Silva-Cunha A
    Curr Eye Res; 2006 Jun; 31(6):525-34. PubMed ID: 16769612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits.
    Wilson TW; Chan HS; Moselhy GM; Heydt DD; Frey CM; Gallie BL
    Arch Ophthalmol; 1996 Nov; 114(11):1390-5. PubMed ID: 8906030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies.
    Yu Y; Chen D; Li Y; Yang W; Tu J; Shen Y
    Drug Deliv; 2018 Nov; 25(1):888-899. PubMed ID: 29631468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits.
    Wang M; Liu W; Lu Q; Zeng H; Liu S; Yue Y; Cheng H; Liu Y; Xue M
    Retina; 2012; 32(10):2158-64. PubMed ID: 23099451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal ceftriaxone in a rabbit model. Dose- and time-dependent toxic effects and pharmacokinetic analysis.
    Shockley RK; Jay WM; Friberg TR; Aziz AM; Rissing JP; Aziz MZ
    Arch Ophthalmol; 1984 Aug; 102(8):1236-8. PubMed ID: 6087776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
    Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DFPE, partially fluorinated ether: a novel approach for experimental intravitreal tamponade.
    Santos RA; Keegan DJ; Fuchs BS; Song BJ; Avila MP; Simpson N; Sparrow JR; Chang S
    Retina; 2013 Jan; 33(1):120-7. PubMed ID: 22810148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.